ArticleHarm reduction journal2021
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
Article in Harm reduction journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 46 citations in OpenAlex.
- Key and evolving needs of service providers in women's harm reduction centers during the COVID-19 pandemic.Harm reduction journal · 2025Article
- Impacts of the COVID-19 pandemic on supervised consumption service delivery in Vancouver and Surrey, Canada from the perspective of service providers.Discover public health · 2025Article
- Changes in harm reduction service providers professional quality of life during dual public health emergencies in Canada.Harm reduction journal · 2024Article
- Epidemiology of acute infections in people who inject drugs in Australia.Drug and alcohol review · 2024Review
- Upper Extremity Infection Related to Intravenous Drug Use: Considering the True Cost of the COVID-19 Pandemic and Lockdown.Hand (New York, N.Y.) · 2023Article
- The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.Addiction (Abingdon, England) · 2023Article
- Supervised smoking facility access, harm reduction practices, and substance use changes during the COVID-19 pandemic: a community-engaged cross-sectional study.Harm reduction journal · 2023Article
- The impact of the COVID-19 pandemic on access to supervised consumption programs.Substance abuse treatment, prevention, and policy · 2023Article
- "The Drug Sellers Were Better Organized than the Government": A Qualitative Study of Participants' Views of Drug Markets during COVID-19 and Other Big Events.International journal of environmental research and public health · 2023Article
- Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns.Frontiers in public health · 2023Article
- Health service utilisation and access for people who inject drugs during COVID-19.Drug and alcohol review · 2022Review
- Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia.Addiction (Abingdon, England) · 2022Article
- HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.Global health, science and practice · 2022Article
- Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis.Addiction science & clinical practice · 2022Article
- "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston.Journal of substance abuse treatment · 2022Article
- The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study.Harm reduction journal · 2022Article
- The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.The International journal on drug policy · 2022Article
- Providing Housing First services for an underserved population during the early wave of the COVID-19 pandemic: A qualitative study.PloS one · 2022Article
- A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.Harm reduction journal · 2021Article
- Assessing Drug Consumption Rooms and Longer Term (5 Year) Impacts on Community and Clients.Risk management and healthcare policy · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 1 country.
Funding
Abstract
The COVID-19 crisis has had profound impacts on health service provision, particularly those providing client facing services. Supervised injecting facilities and drug consumption rooms across the world have been particularly challenged during the pandemic, as have their client group-people who consume drugs. Several services across Europe and North America closed due to difficulties complying with physical distancing requirements. In contrast, the two supervised injecting facilities in Australia (the Uniting Medically Supervised Injecting Centre-MSIC-in Sydney and the North Richmond Community Health Medically Supervised Injecting Room-MSIR-in Melbourne) remained open (as at the time of writing-December 2020). Both services have implemented a comprehensive range of strategies to continue providing safer injecting spaces as well as communicating crucial health information and facilitating access to ancillary services (such as accommodation) and drug treatment for their clients. This paper documents these strategies and the challenges both services are facing during the pandemic. Remaining open poses potential risks relating to COVID-19 transmission for both staff and clients. However, given the harms associated with closing these services, which include the potential loss of life from injecting in unsafe/unsupervised environments, the public and individual health benefits of remaining open are greater. Both services are deemed 'essential health services', and their continued operation has important benefits for people who inject drugs in Sydney and Melbourne.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.